<h3>Gainers</h3>
<ul>
<li>KalVista Pharmaceuticals (NASDAQ:KALV) shares rose 38.5% to $26.66 during Wednesday's pre-market session. The company's market cap stands at $985.5 million. </li>
<li>GlucoTrack (NASDAQ:GCTK) stock increased by 26.64% to $1.06. </li>
<li>Akanda (NASDAQ:AKAN) stock increased by 16.52% to $20.38. The market value of their outstanding shares is at $9.3 million. </li>
<li>NeoGenomics (NASDAQ:NEO) shares increased by 14.19% to $10.3. The market value of their outstanding shares is at $1.1 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Icon (NASDAQ:ICLR) shares rose 14.15% to $117.0. The company's market cap stands at $7.8 billion. </li>
<li>Traws Pharma (NASDAQ:TRAW) stock rose 12.39% to $1.36. The market value of their outstanding shares is at $12.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BiomX (AMEX:PHGE) shares fell 18.6% to $0.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $7.5 million. </li>
<li>CollPlant Biotechnologies (NASDAQ:CLGN) shares declined by 12.95% to $0.34. The company's market cap stands at $4.9 million. </li>
<li>China Pharma Holding (AMEX:CPHI) shares fell 11.35% to $0.5. The company's market cap stands at $2.8 million. </li>
<li>GE HealthCare Techs (NASDAQ:GEHC) shares fell 10.26% to $61.48. The market value of their outstanding shares is at $31.2 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Intellia Therapeutics (NASDAQ:NTLA) stock decreased by 9.1% to $12.0. The company's market cap stands at $1.5 billion. </li>
<li>Onconetix (NASDAQ:ONCO) shares declined by 8.99% to $0.7. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GCTK

KALV

In Wednesday's pre-market session, KalVista Pharmaceuticals saw a significant gain of 38.5%, reaching $26.66, with a market cap of $985.5 million. Other notable gainers included GlucoTrack (+26.64%), Akanda (+16.52%), and NeoGenomics (+14.19%). Conversely, BiomX experienced the largest decline, falling 18.6% to $0.7. Other losers included CollPlant Biotechnologies (-12.95%) and China Pharma Holding (-11.35%). The Q1 earnings report was released today, impacting stock movements.

benzinga_article

GlucoTrack

Neogenomics

KalVista Pharma

Akanda

Health Care Select Sector SPDR

Invesco Nasdaq Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

VanEck Biotech ETF

SPDR S&P Biotech

VG Health

Ark Genomic Revolution ETF

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

ICON

Traws Pharma

BiomX

CollPlant Biotech

China Pharma

GE HealthCare Tech

Intellia Therap

Onconetix

12 Health Care Stocks Moving In Wednesday's Pre-Market Session